The substernal extravascular implantable cardioverter-defibrillator showed successful defibrillation, pacing, and sensing with no acute major complications in most patients.
Is the chronic implantation of a substernal extravascular implantable cardioverter-defibrillator feasible and safe?
First-in-human evaluation demonstrates that a substernal extravascular ICD is feasible and acutely safe for pacing and defibrillation.
Absolute Event Rate: 0% vs 0%
This first-in-human evaluation of an EV ICD demonstrated the feasibility of substernal lead placement, defibrillation, and pacing with a chronically implanted system. There were no acute major complications, and pacing, defibrillation, and sensing performance at implantation were successful in most patients. (Extravascular ICD Pilot Study EV ICD; NCT03608670).
Crozier et al. (Wed,) reported a other. The substernal extravascular implantable cardioverter-defibrillator showed successful defibrillation, pacing, and sensing with no acute major complications in most patients.